Literature DB >> 33566687

Starting Antihypertensive Drug Treatment With Combination Therapy: Controversies in Hypertension - Con Side of the Argument.

Zhen-Yu Zhang1, Yu-Ling Yu1, Kei Asayama1,2,3,4, Tine W Hansen4,5, Gladys E Maestre4,6,7, Jan A Staessen4,8.   

Abstract

Entities:  

Keywords:  angiotensin-converting enzyme inhibitors; angiotensin-receptor blockers; blood pressure; diuretics; hypertension; renin

Year:  2021        PMID： 33566687      PMCID： PMC7884241          DOI： 10.1161/HYPERTENSIONAHA.120.12858

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  92 in total

1.  Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.

Authors:  Jeppe N Rasmussen; Alice Chong; David A Alter
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

2.  Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapy.

Authors:  Weiyi Yang; Kristijan H Kahler; Thomas Fellers; John Orloff; Joanne Chang; Arielle G Bensimon; Eric Q Wu; Chun-Po Steve Fan; Andrew P Yu
Journal:  J Med Econ       Date:  2011-03-30       Impact factor: 2.448

Review 3.  Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment.

Authors:  Francesco Vittorio Costa
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-10

4.  Cardioprotective Effect of Thiazide-Like Diuretics: A Meta-Analysis.

Authors:  Peng Chen; Sandip Chaugai; Fujie Zhao; Dao Wen Wang
Journal:  Am J Hypertens       Date:  2015-04-29       Impact factor: 2.689

5.  A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial.

Authors:  Ross D Feldman; Guang Y Zou; Margaret K Vandervoort; Cindy J Wong; Sigrid A E Nelson; Brian G Feagan
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

6.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Authors:  Judith A Whitworth
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

7.  The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization.

Authors:  Hans Lithell; Lennart Hansson; Ingmar Skoog; Dag Elmfeldt; Albert Hofman; Bertil Olofsson; Peter Trenkwalder; Alberto Zanchetti
Journal:  J Hypertens       Date:  2004-08       Impact factor: 4.844

8.  Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment.

Authors:  Jan Ostermann; Axel Mühlbacher; Derek S Brown; Dean A Regier; Amy Hobbie; Andrew Weinhold; Noor Alshareef; Caroline Derrick; Nathan M Thielman
Journal:  Value Health       Date:  2020-07-18       Impact factor: 5.725

Review 9.  Interaction between renin and the autonomic nervous system in hypertension.

Authors:  S Julius
Journal:  Am Heart J       Date:  1988-08       Impact factor: 4.749

10.  Value as the key concept in the health care system: how it has influenced medical practice and clinical decision-making processes.

Authors:  Chiara Marzorati; Gabriella Pravettoni
Journal:  J Multidiscip Healthc       Date:  2017-03-21
View more
  1 in total

Review 1.  Comparison between the world health organization (WHO) and international society of hypertension (ISH) guidelines for hypertension.

Authors:  Pringgodigdo Nugroho; Hubert Andrew; Kelvin Kohar; Chairina Azkya Noor; Aida Lydia Sutranto
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.